CFSAN Constituent Update - FDA to Extend Comment Period on Draft Guidance for Industry: Action Level for Inorganic Arsenic in Rice Cereals for Infants

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: CFSAN Constituent Update - FDA to Extend Comment Period on Draft Guidance for Industry: Action Level for Inorganic Arsenic in Rice Cereals for Infants

Center for Food Safety and Applied Nutrition - Constituent Update
http://www.fda.gov/Food/NewsEvents/ConstituentUpdates/default.htm

---

FDA to Extend Comment Period on Draft Guidance for Industry: Action Level for Inorganic Arsenic in Rice Cereals for Infants

June 29, 2016

Due to maintenance on the Federal eRulemaking portal from July 1 through July 5, 2016, the FDA will provide stakeholders an additional 14 days to comment on the following request for scientific data, information, and comments that appeared in the Federal Register on April 6, 2016:

• Inorganic Arsenic in Rice Cereals for Infants: Action Level; Draft Guidance for Industry; Supporting Document for Action Level for Inorganic Arsenic in Rice Cereals for Infants; Arsenic in Rice and Rice Products Risk Assessment: Report; Availability

The comment period, originally scheduled to close on July 5, 2016, will now close on July 19, 2016.

To electronically submit comments to the docket, visit www.regulations.gov and type FDA-2016-D-1099 in the search box.

To submit comments to the docket by mail, use the following address. Be sure to include docket number FDA-2016-D-1099 on each page of your written comments.

Division of Dockets Management
HFA-305
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852

For more information:

• Federal Register Notice Extending the Comment Period
• Arsenic in Rice and Rice Products
• FDA Proposes Limit for Inorganic Arsenic in Infant Rice Cereal

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

 

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)